x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:12:40

Oxford, UK based OMass Therapeutics, experts in the...

BiotechTV - News ·

2025/10/09

CEO Ros Deegan discusses the deal and the path to getting there, and she highlights some of OMass' other programs the company is driving forward alone, including an MC2 antagonist. Plus, the company's unique expertise in the use of mass spec.

en-us

00:07:04

NYSE Market Strategist Eric Criscuolo discusses...

BiotechTV - News ·

2025/10/09

He discusses the rally biotech has had of late, and that was boosted by Pfizer's deal with the White House. Plus, how interest rates, employment, and other factors are affecting the broader economy, and might impact biotech.

en-us

00:23:20

Immuneering's CEO walks us through the company's MEK...

BiotechTV - News ·

2025/10/09

Ben Zeskind describes the company's 9 month follow-up for atebimetinib + mGnP, which showed 86% overall survival and 53% progression free survival.

en-us

00:41:11

R.W. Baird Managing Director & Senior Biotech Analyst...

BiotechTV - News ·

2025/10/08

He shares his thoughts on Soleno, Sarepta, Lexeo, Enanta, Crinetics, Vertex, Xenon, and more.

en-us

00:15:58

Biotech veteran David Hung talks about the launch of...

BiotechTV - News ·

2025/10/08

He discusses the clinical profile of IBTROZI, how the launch is going, and describes other work the company is doing in precision medicine. Plus, his take on the biotech environment currently.

en-us

00:20:34

Complement Therapeutics received IND clearance from...

BiotechTV - News ·

2025/10/08

CEO Rafiq Hasan describes to BiotechTV's Amy Brown during an interivew in London how this program works, and he compares and contrasts it to more traditional therapies that are on the market currently. Plus, and overview of Complement's other programs and operations.

en-us

00:06:38

Align Summit: Cambridge based Quiver Bioscience is...

BiotechTV - News ·

2025/10/07

Co-Founder & CEO Graham Dempsey describes the different between Nav1.7 and 1.8, and why he thinks having an ASO approach will succeed in 1.7 where small molecules have not. Plus, an epilepsy program, and what it is like being an earlier stage company today.

en-us

00:05:20

Align Summit: Toronto based HDAX Therapeutics...

BiotechTV - News ·

2025/10/07

Co-Founder & CEO Nabanita Nawar describes the need for tackle HDAC6 with better chemistry. Plus, what it is like being a biotech startup in Canada today.

en-us

00:08:30

Align Summit: Allston based KiraGen Bio is aiming to...

BiotechTV - News ·

2025/10/07

Co-Founder and CEO Aaron Edwards describes the rational behind this approach, as opposed charging the cells with cytokines or removing their brakes. He also explains why KiraGen is looking abroad to do its first clinical trials.

en-us

00:16:51

Soufflé Therapeutics exited stealth today with the...

BiotechTV - News ·

2025/10/07

CEO Amir Nashat, who has decades of experience in biotech at Polaris Partners, describes the work Soufflé has been doing to catalogue often rare targets and design ligands that carry payloads to them such as siRNAs and ASOs. The company plans to be in the clinic next year and is starting out with muscle conditions.

en-us

00:13:07

Brian Alexander, former CEO of Foundation Medicine,...

BiotechTV - News ·

2025/10/03

The company recently received a grant from the Michael J. Fox Foundation to work on Parkinson's, and has existing partnerships with companies such as Novo and Charles River.

en-us

00:13:22

Aerska launched in the UK today with $21M in...

BiotechTV - News ·

2025/10/01

Chief Executive Officer Jack O'Meara, who previously founded Ochre Bio in the RNA space, describes the potential benefits of using brain shuttles and why the time is right for this approach. Plus, the company's business model and what to expect next.

en-us

00:22:29

Enanta Pharmaceuticals' CEO and CMO discuss data...

BiotechTV - News ·

2025/09/29

CEO Jay Luly and CMO Scott Rottinghaus describe today's data, which was focused on high risk adults. They explain how safety and efficacy were measured, and what the learnings were from a handful of endpoints. Plus, Enanta's earlier stage I&I programs targeting KIT and STAT6.

en-us

00:15:21

Sunny Kumar, a partner at Informed Ventures, and an...

BiotechTV - News ·

2025/09/26

He discussed how current technologies are making healthcare more effecient today, how new technologies are opening new markets, and how the practice of medicine might be changed in the process.

en-us

00:09:59

Eko Health's Co-Founder & CEO shows BiotechTV the...

BiotechTV - News ·

2025/09/19

Connor Landgraf shows us the product and describes recent data the company compiled in the UK showing the benefits of using this digital and AI enhanced device over a traditional stethoscope.

en-us

00:13:04

Sweden's Annoca announced a $46M raise last month to...

BiotechTV - News ·

2025/09/18

He describes the raise and the trial, which is an umbrella study that will test products against three different mutations. Plus, work on vaccines and a non-oncology cell therapy program, and partnership opportunities.

en-us

00:16:12

Xspray Pharma makes protein kinase inhibitors that...

BiotechTV - News ·

2025/09/17

CEO Per Andersson walks us through the benefits of designing kinase inhibitors this way, which should not be affected by the pH of the stomach. He shows us the unique manufacturing equipment, and walks us through a pipeline that includes dasatinib, nilotinib, axitinib, and cabozantinib.

en-us

00:09:01

Pareto Securities Healthcare Conference: Egetis...

BiotechTV - News ·

2025/09/16

CEO Nicklas Westerholm walks us through the condition, which is an X-chromosome linked rare disease that affects men, and he describes how the launch is going in Europe, and plans for an FDA meeting.

en-us

00:09:16

Pareto Securities' Healthcare Conference: Cinclus...

BiotechTV - News ·

2025/09/16

CEO Christer Ahlberg describes the shortcomings of today's medicines, and why he believes a P-CAB is the answer. This therapy originated at AstraZeneca, though Cinclus owns it outright today, and is in a phase 3 that just started.

en-us

00:10:59

Pareto Securities' Healthcare Conference: Biotech...

BiotechTV - News ·

2025/09/16

He sees an optimistic turn after a challenging couple of years. Plus, highlighting Vicor, Camurus, Oculis, and BioArctic.

en-us

267 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter